NTT DATA and ENGIE Announce Strategic Partnership to Power Sustainable AI and Data Center Growth

Submitted by Anonyme on 2026-07-29T11:15:01+02:00
NTT DATA, a global leader in AI, digital business and technology services, and ENGIE, a major player in the energy transition, today announced a strategic partnership to support the decarbonization, energy resilience and sustainable expansion of NTT DATA’s global data center operations. By combining ENGIE’s global leadership in renewable energy and low‑carbon solutions with NTT DATA’s infrastructure and technology services, the partnership secures long-term access to competitive renewable energy and power solutions that support the...
Anglais

ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business Officer

Submitted by Anonyme on 2026-08-10T10:15:01+02:00
ROCKVILLE, MD /ACCESS Newswire/ August 10, 2026 / ABL Inc and Ascend Advanced Therapiestoday announced the appointment of Suman Subramanian as Chief Business Officer (CBO), further strengthening the Company's commercial leadership and its commitment to supporting customers with the development and...
Anglais

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

Submitted by Anonyme on 2026-08-10T12:15:01+02:00
BeOne Medicines Ltd.(Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, andRevolution Medicines, Inc.(Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne...
Anglais

4Moving Biotech Completes Enrollment in Phase 2a INFLAM MOTION Study Evaluating First-in-class Intra-articular GLP-1 Therapy Targeting Synovitis as a Driver of Pain and Disease Progression in Knee Osteoarthritis

Submitted by Anonyme on 2026-08-04T07:15:01+02:00
4Moving Biotech (4MB), a clinical-stage biotechnology company dedicated to developing first-in-class therapies for inflammatory knee osteoarthritis, today announced the completion of patient enrollment in INFLAM MOTION, its international Phase 2a proof-of-concept study. The trial is evaluating the efficacy and safety of 4P004, an investigational intra-articular GLP-1 receptor agonist designed to address the...
Anglais

Kioxia Announces KIOXIA GP1 Series Super High IOPS SSDs for AI Applications

Submitted by Anonyme on 2026-08-04T07:15:01+02:00
Kioxia Corporation today announced the KIOXIA GP1 Series PCIe®6.0 NVMe™ SSDs, the first product in its KIOXIA GP Series of Super High IOPS SSDs optimized for GPU direct access. Building on the KIOXIA GP Series technology introduced earlier this year1, the KIOXIA GP1 Series delivers up to 10 million random read IOPS2using KIOXIA XL-FLASH™ generation 2 flash memory, enabling flash-based memory extension to help address the growing performance and memory demands of AI infrastructure. Evaluation samples will be available to select customers by the end of 20263. The KIOXIA GP1 Series will...
Anglais
Subscribe to